NBC News

Apricus Biosciences Will Request Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland, Based on Guidance From Swiss Regulatory Authorities

SAN DIEGO, May 19, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that it will file a marketing application in Switzerland for Vitaros ® as a ...
NBC News

Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

SAN DIEGO, April 28, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that it has filed a marketing application in Europe for Vitaros ® as a treatment ...
Medscape

Topical ED Treatment Vitaros Approved in Europe

Apricus Biosciences has received European approval to market alprostadil 0.3% topical cream (Vitaros) for the treatment of erectile dysfunction (ED), the company announced today. Vitaros is a ...
FierceBiotech

Apricus Biosciences to File for Market Authorization to Sell Vitaros® for Erectile Dysfunction in Latin America

My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about APRI -- Potential Market Size for Vitaros® for Erectile Dysfunction in ...
San Diego Union-Tribune

Apricus licenses erectile dysfunction cream in Israel and Palestinian Territories

An Israeli pharmaceutical and consumer health products company has agreed to sell Vitaros, an erectile dysfunction cream made by Apricus Biosciences, in that country and the Palestinian Territories, ...